SCHEMBL2452841

SCHEMBL2452841

COc1cccc(C(=O)N(C)c2cccs2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 3/20 0.54
KDM4E B2RXH2 3/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
CES2 O00748 1/20 0.51
CES1 P23141 1/20 0.51
NPC1 O15118 5/20 0.50
PARP1 P09874 1/20 0.49
HSD17B1 P14061 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MAPT P10636 1/20 0.48
ABL1 P00519 1/20 0.47
BCR P11274 1/20 0.47
LMNA P02545 2/20 0.46
TP53 P04637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
RAB9A P51151 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2417968 0.79 KMT2A (0.49) KDM4ECES2CES1NPC1ALDH1A1
SCHEMBL2540656 0.77 CES2 (0.67) HSD17B2CES2CES1NPC1PARP1
SCHEMBL30870831 0.77 CES2 (0.67) HSD17B2CES2CES1NPC1PARP1
SCHEMBL11218744 0.77 HSD17B2 (0.68) HSD17B2KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL2456052 0.76 ALDH1A1 (0.52) CES2CES1NPC1ALDH1A1MAPT
SCHEMBL2199255 0.76 CES2 (0.65) HSD17B2KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL7886795 0.75 CES2 (0.70) KDM4ECES2CES1NPC1PARP1
SCHEMBL2353790 0.75 CES2 (0.59) HSD17B2KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL307622 0.74 CES2 (0.62) HSD17B2KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL23041066 0.74 NPC1 (0.65) CES2CES1NPC1PARP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663193-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES Applied Research Systems ARS Holding N.V. (AN) 2006-06-07 EP claimed
WO-2005025558-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES APPLIED RESERACH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO claimed
US-8012995-B1 Pharmaceutically active sulfonamide derivatives MERCK SERONO SA (CH) 2011-09-06 US disclosed
US-7544700-B2 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein JunKinases LABORATOIRES SERONO SA (CH) 2009-06-09 US disclosed